AVN-999

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAVN-999
Drug Alias Namevasopressin V1a receptor antagonist (Azevan Pharmaceuticals/Lehigh University/Northeastern University)AVN-576AVN-999
ClassificationSmall molecules
Mechanisms of ActionVasopressin V1a receptor antagonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAzevan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLehigh UniversityNortheastern UniversityAzevan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A